RNU6-1116P

Across TCGA pan-cancer cohorts, RNU6-1116P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RNU6-1116P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNU6-1116P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-1116P expression acts as an unfavorable survival marker.

KIRC, PAAD, and BRCA are the cancer types where RNU6-1116P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	III,IV	0.357	0.659	<.001	90	view →
PAAD	OS	Tertile	All	0.100	0.590	<.001	72	view →
BRCA	OS	Tertile	III,IV	0.207	0.833	<.001	66	view →
TGCT	DFS	Tertile	II,III,IV	0.015	0.919	<.001	54	view →
STAD	OS	Tertile	IV	0.063	0.510	<.001	45	view →
ACC	DFS	Tertile	All	0.066	0.667	.002	36	view →
UCEC	OS	Tertile	IV	0.308	0.748	.009	36	view →
THYM	DFS	Tertile	All	0.174	0.759	.028	27	view →
SKCM	OS	Tertile	III,IV	0.296	0.707	.019	24	view →
GBM	DFS	Tertile	All	0.071	0.288	.009	18	view →
LIHC	OS	Tertile	All	0.025	0.775	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RNU6-1116P–KIRC (DFS)

Open the KIRC breakdown →